Tirzepatide
This medication requires a valid prescription from a licensed physician.

Tirzepatide

Tirzepatide injection

Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown remarkable efficacy in clinical trials, with participants achieving an average weight loss of up to 22.5% of body weight. It works through a novel dual-action mechanism targeting two key metabolic hormones.

Available Dosages

2.5 mg (Starter Dose) 4-week supply
$349 $1100
5 mg 4-week supply
$399 $1300
7.5 mg 4-week supply
$449 $1500
10 mg 4-week supply
$499 $1700
12.5 mg 4-week supply
$549 $1900
15 mg (Maintenance Dose) 4-week supply
$599 $2100
or Start Your Evaluation

A licensed physician will review your health profile and determine if this medication is appropriate for you.

Medical Information

How It Works

Tirzepatide is administered as a once-weekly subcutaneous injection. It is the first dual GIP and GLP-1 receptor agonist, targeting two incretin hormones involved in blood sugar regulation and appetite control. Dosing starts low and is titrated upward every 4 weeks.

Potential Side Effects

The most common side effects include:

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Dyspepsia
  • Abdominal pain
  • Injection site reactions

Side effects are typically mild and tend to improve as your body adjusts to the medication. Contact your healthcare provider if you experience severe or persistent side effects.